Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Head & Neck 1Gastrointestinal 1

Conditions

Venous Thromboembolism 11Venous Thrombosis 4Neoplasms 4Thrombosis 3Pulmonary Embolism 3Thrombocytopenia 1Sarcoma 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Bone Neoplasms 1Abdominal Neoplasms 1

Interventions

apixaban 4Enoxaparin 3Rivaroxaban 2Heparin, Low-Molecular-Weight 2Dalteparin 2edoxaban 1Warfarin 1Tinzaparin 1Simvastatin 1Observation 1Fondaparinux 1Data Collection 1Dabigatran 1Aspirin 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Thrombosis × Enoxaparin × Classical hematology × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡